← FDA DRUG APPROVALS

FDA NDA · NDA021310

ALORA

Sponsor: WATSON LABS

APPLICATION
NDA021310
TYPE
NDA
ORIGINAL APPROVAL
2002-04-05
LATEST ACTION
2002-04-05
ROUTE
TRANSDERMAL
DOSAGE FORM
FILM, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

ALORAPrescription
ESTRADIOL N/A · FILM, EXTENDED RELEASE · TRANSDERMAL

Approval history

2002-04-05Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →